Shams Sedigheh, Azari-Yam Aileen, Safavi Moeinadin, Zamani Zahra, Sotoudeh-Anvari Maryam, Sharifzadeh Ekbatani Meisam, Haghi-Ashtiani Mohammad-Taghi, Mozafari Fatemeh, Yaghmaie Bahareh, Shafeghat Leila
Pathology Department, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Int J Pediatr. 2022 Jul 29;2022:9390327. doi: 10.1155/2022/9390327. eCollection 2022.
COVID-19 is an acute viral disease that has so far infected more than 200 million and killed more than four million worldwide. It affects the immune system and other organs. Here, we investigated the level of free plasma amino acids in COVID-19 patients and compared them with non-COVID-19 subjects. We also compared amino acids levels in critically ill patients admitted to the intensive care unit (ICU) with non-ICU patients and expired and recovered patients. Twenty-six COVID-19 patients and 32 non-COVID-19 subjects were included in the study. The mean of glutamic acid, serine, glycine, threonine, phenylalanine, leucine, lysine, alanine, arginine, aspartic acid, and ornithine was significantly higher in cases than controls. In addition, the mean of glutamine was significantly lower in patients than controls (443.89 ± 254.31 vs. 651.73 ± 107.38, PV < 0.001). Low level of glutamine and isoleucine was seen in the majority of ICU and expired patients, respectively. Logistic regression analysis showed low level of isoleucine as a predictor variable in mortality ( = 0.02, EXP () = 16.5, and CI 95% = (1.48, -183.07)). There was a positive and significant relationship between some amino acids levels, serum liver enzymes, and sodium concentrations. There was also a significant but negative correlation between histidine levels, ESR, and ferritin. Phenylalanine had a highly positive relationship with serum procalcitonin in patients ( = 0.534, PV = 0.015). Our studies have shown the alteration of plasma amino acids concentration in COVID-19 patients. These changes are more evident in critically ill and at-risk patients.
新型冠状病毒肺炎(COVID-19)是一种急性病毒性疾病,迄今为止,全球已有超过2亿人感染,400多万人死亡。它会影响免疫系统和其他器官。在此,我们调查了COVID-19患者血浆游离氨基酸水平,并将其与非COVID-19受试者进行比较。我们还比较了重症监护病房(ICU)收治的重症患者与非ICU患者、死亡患者和康复患者的氨基酸水平。本研究纳入了26例COVID-19患者和32例非COVID-19受试者。病例组中谷氨酸、丝氨酸、甘氨酸、苏氨酸、苯丙氨酸、亮氨酸、赖氨酸、丙氨酸、精氨酸、天冬氨酸和鸟氨酸的平均值显著高于对照组。此外,患者组中谷氨酰胺的平均值显著低于对照组(443.89±254.31 vs. 651.73±107.38,PV<0.001)。大多数ICU患者和死亡患者分别出现谷氨酰胺和异亮氨酸水平降低。逻辑回归分析显示,异亮氨酸水平低是死亡率的预测变量(=0.02,EXP()=16.5,95%CI=(1.48,-183.07))。一些氨基酸水平、血清肝酶和钠浓度之间存在正相关且显著的关系。组氨酸水平、红细胞沉降率(ESR)和铁蛋白之间也存在显著但负相关。患者中苯丙氨酸与血清降钙素原呈高度正相关(=0.534,PV=0.015)。我们的研究表明COVID-19患者血浆氨基酸浓度发生了改变。这些变化在重症和高危患者中更为明显。